Saint Joseph's Translational Research Institute, Saint Joseph's Hospital of Atlanta, GA, USA.
EuroIntervention. 2009 Nov;5(5):619-26. doi: 10.4244/eijv5i5a99.
The present study was designed to evaluate a novel third generation bare-metal stent (BMS) comprised of an ultra-thin-strut, cobalt-chromium platform with fixed geometry, uniform cell size, and superior surface finish in a porcine coronary artery model.
A total of 47 BMS of two types were implanted in pig coronary arteries using QCA to optimise stent apposition: a commercially available cobalt alloy thin-strut stent (91 microm) as control (Driver; n=17), and an ultra-thin-strut (65 microm) cobalt-chromium stent (Protea; n=18). Animals underwent angiographic restudy and termination one week and one month post-implant for coronary artery histology. In addition, 12 overlapping Protea stents were analysed at one month. At one week, comparable thin neointima and mild inflammation were observed in both groups. At one month, Protea demonstrated significantly lower angiographic % stenosis (2+/-1% vs. 17+/-5%, p=0.006), intimal thickness (0.11+/-0.01 mm vs. 0.23+/-0.03 mm, p=0.003), and histologic % area stenosis (19+/-2% vs. 32+/-3%, p=0.003). Mean stent strut injury scores were low and similar between groups. Angiographic % stenosis, intimal thickness, and histologic % area stenosis of overlapping Protea stents were 3+/-1%, 0.13+/-0.01 mm, and 22+/-2%, respectively, and similar to the single Protea group. Stable fibrocellular neointimal incorporation, with complete endothelialisation and minimal inflammation, were observed at one month in all stents, including overlapped Protea segments.
When compared to a commercially available cobalt alloy BMS, the new third generation Protea stent demonstrated favourable coronary arterial response with significant reduction of neointimal formation in the porcine model. Our results showed how seemingly trivial improvements to the BMS technology can result in substantial biological responses. Future, long-term investigations are needed to ascertain the clinical applicability and implications of these findings.
本研究旨在评估一种新型第三代裸金属支架(BMS),该支架由超薄壁、钴铬平台组成,具有固定的几何形状、均匀的单元尺寸和卓越的表面光洁度,应用于猪冠状动脉模型中。
使用 QCA 优化支架贴壁,将两种类型的总共 47 个 BMS 植入猪冠状动脉中:一种是市售的钴合金薄壁支架(91 微米)作为对照(Driver;n=17),另一种是超薄壁(65 微米)钴铬支架(Protea;n=18)。动物在植入后一周和一个月进行血管造影复查和终止,以进行冠状动脉组织学检查。此外,在一个月时分析了 12 个重叠的 Protea 支架。在一周时,两组的新生内膜均较薄,炎症较轻。一个月时,Protea 支架的血管造影狭窄率(2+/-1%对 17+/-5%,p=0.006)、内膜厚度(0.11+/-0.01 毫米对 0.23+/-0.03 毫米,p=0.003)和组织学狭窄率(19+/-2%对 32+/-3%,p=0.003)均显著降低。两组支架的平均支架结构损伤评分较低且相似。重叠的 Protea 支架的血管造影狭窄率、内膜厚度和组织学狭窄率分别为 3+/-1%、0.13+/-0.01 毫米和 22+/-2%,与单个 Protea 支架组相似。所有支架(包括重叠的 Protea 段)在一个月时均观察到稳定的纤维细胞性新生内膜形成,完全内皮化,炎症轻微。
与市售的钴合金 BMS 相比,新型第三代 Protea 支架在猪模型中表现出有利的冠状动脉反应,新生内膜形成明显减少。我们的结果表明,BMS 技术的微小改进如何能带来实质性的生物学反应。未来需要进行长期研究,以确定这些发现的临床适用性和意义。